Clinical characteristics of pediatric cutaneous mastocytosis and the association with allergic comorbidities and inborn errors of immunity
Dicle Tıp Dergisi · 05.06.2026 · 53 (2) · 285-295
DOI: 10.5798/dicletip.1963920 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dicle Tıp Dergisi, online erschienen am 05.06.2026. Verfasst von Ozan Kapçay und 2 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Objective
Cutaneous mastocytosis (CM) is the most common form of mastocytosis in childhood; however, data on its clinical course and associated allergic and immunologic features remain limited. This study aimed to characterize the clinical phenotype of pediatric CM and to evaluate the frequency of concomitant allergic diseases and inborn errors of immunity (IEI).
Methods
This retrospective study included 17 pediatric patients diagnosed with CM between 2007 and 2025. Demographic characteristics, clinical findings, laboratory parameters, allergic sensitization, immunologic evaluation, and follow-up outcomes were systematically analyzed.
Results
The cohort showed a male predominance (64.7%), with a median age at symptom onset of 14.2 months. Maculopapular cutaneous mastocytosis was the most frequent subtype (82.3%), followed by diffuse CM and solitary mastocytoma. During a median follow-up of 4.5 years, 11.2% of patients achieved complete regression, 47.0% showed partial regression, 35.2% remained stable, and 5.8% exhibited progression. No cases of systemic mastocytosis, anaphylaxis, or mortality were observed.Eosinophilia was present in 23.5% and hepatosplenomegaly in 11.7% of patients, without evidence of organ dysfunction. Serum immunoglobulin levels and vaccine responses were within normal ranges in all evaluated patients, and no IEI was identified. Elevated IgE levels were detected in 17.6%, while allergic sensitization was documented in 29.4%. Allergic comorbidities were observed in 41.1% of patients, most commonly allergic rhinitis.
Conclusion
Pediatric CM predominantly presents as an early-onset, skin-limited disease with a favorable and often regressive clinical course. The frequency of allergic diseases and sensitization does not appear to be increased compared to the general population, and humoral immune function remains preserved. These findings support a selective, clinically driven approach to immunologic evaluation rather than routine screening in children with CM.
Zitieren
APA
Kapçay, O., Şahin, F. D., & Kılıç, M. (2026). Clinical characteristics of pediatric cutaneous mastocytosis and the association with allergic comorbidities and inborn errors of immunity. Dicle Tıp Dergisi, 53(2), 285-295. https://doi.org/10.5798/dicletip.1963920
Vancouver
Kapçay O, Şahin FD, Kılıç M. Clinical characteristics of pediatric cutaneous mastocytosis and the association with allergic comorbidities and inborn errors of immunity. Dicle Tıp Dergisi. 2026;53(2):285-295. doi:10.5798/dicletip.1963920
BibTeX
@article{Kapay2026,
author = {Kapçay, Ozan and Şahin, Filiz Demir and Kılıç, Mehmet},
title = {Clinical characteristics of pediatric cutaneous mastocytosis and the association with allergic comorbidities and inborn errors of immunity},
journal = {Dicle Tıp Dergisi},
year = {2026},
volume = {53},
number = {2},
pages = {285--295},
doi = {10.5798/dicletip.1963920}
}
EUVIMED